BCR and leukemia: Leukaemia blasts (pre-BCR+ ALL) can thus hijack the pre-BCR signalling pathway to induce differentiation arrest and avoid clonal extinction, and reactivating this pathway may be an attractive therapeutic target (as reviewed in Ref.